Oxidative stress has been recognized as a central feature of smoke induced chronic obstructive pulmonary disease (COPD). Imbalance between oxidant and antioxidant enzymes is also an established fact in these patients. But studies in regard to stable COPD patients and effect of vitamin E supplementation are lacking. Thirty patients with COPD were included in the study. Their baseline clinical examination, spirometry, plasma malondialdehyde (MDA), alpha-tocopherol and red blood cell superoxide dismutase (SOD) levels were measured. Twenty healthy non-smokers who were matched for age and sex served as controls. All the above parameters were repeated after 12 weeks of supplementation with 400IU of vitamin E daily. The mean malondialdehyde levels in the patients at baseline were higher than controls (5-91 ±1.23 nmol/ml vs 4.55 ± 1.51 nmol/ml,P = 0.001), so also was plasma alpha-tocopherol levels (P<0.00l), while SOD levels were lower in the patients compared to controls (1692 ± 259 units g/Hb vs 2451 ± 131 units g/Hb,P < 0001). Exogenous vitamin E (400 IU per day) supplementation did not bring about any significant change in plasma alpha-tocopherol and SOD levels. The Pearson’s co-efficient of correlation between the levels of MDA, vitamin E, SOD; and spirometric measurements were not significant either on day 1 or after 12 weeks of vitamin E supplementation. The present study shows that initially the plasma lipid peroxide (MDA) levels are high and antioxidants (alpha-tocopherol and SOD) are low in patients with COPD. Exogenous supplementation with vitamin E does not have any significant effect on the spirometric measurements though it brings down the levels of MDA showing attenuation of further damage. However, inclusion of larger number of patients and supplementation with vitamin E for longer periods may throw more light on free radical injury and protective effects of antioxidants.
Volume 45, 2020
Continuous Article Publishing mode
Click here for Editorial Note on CAP Mode